InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: louieblouie post# 315416

Tuesday, 12/15/2020 12:14:31 PM

Tuesday, December 15, 2020 12:14:31 PM

Post# of 426380
lb..

Do not be surprised if VSCEPA/Amarin eventually reaches Zombie status. I still maintain the generics have won very little and Amarin if management can get their act together and stop ripping the company off...It could come out of this whole fiasco and become the stock we all know it should be..

The value remains in the drug itself. Something the market is blissfully unaware of...EPA is a very ancient actor and dates back to the very first multicellular animals which were present in the primordial seas going back 500 million years.. These were the ancestors of modern day sponges.. Without EPA controlling the inflammation there would be none of modern day multicellular animals including those of you reading this post.

Despite all these new vaccines coming out. No one really knows how successful they will be...Vaccines have been around for a long time and the history of them in combatting viral pandemics has not been very impressive. The problem is some parts of the virus are very prone to mutations (the broccoli head) and other parts (the stem) remains very stable...It is relatively simple to make a vaccine for the broccoli head ..But the vaccine will not be effecive if the head mutates..The stem would be a better target..but it turns out this is very difficult to do..
For the present we do not know very much about these vaccines,,But we do know the question of how long the immunity lasts, suggests the head has been targeted.

In the serious cases (read fatalities) cytokine storm is the central problem...And it could turn out that EPA's ability to moderate the eicosanoid and PPar receptors...Might actually be more effective than the vaccines in cutting down the serious cases; by moderating inflammation..

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News